Company Filing History:
Years Active: 2002-2003
Title: Innovations in Auto-Immune Disease Treatment by Yukari Kuroiwa
Introduction
Yukari Kuroiwa is a notable inventor based in Yokohama, Japan. She has made significant contributions to the field of photochemotherapy, particularly in the treatment of auto-immune diseases. With a total of 2 patents, her work is paving the way for innovative therapeutic methods.
Latest Patents
Kuroiwa's latest patents focus on novel photochemotherapeutical methods for treating auto-immune diseases. One of her patents describes a method that involves administering mono-L-aspartyl chlorin e6 or mono-L-glutamyl chlorin e6, or a pharmacologically acceptable salt thereof, to patients. Following this, the patient's blood is exposed to ultraviolet rays or laser light to photochemically excite the compound. This method has shown effectiveness in decreasing the level of auto-antibodies in the blood while maintaining high safety standards.
Career Highlights
Yukari Kuroiwa is currently associated with Meiji Seika Kaisha, Ltd., where she continues to develop her innovative approaches to medical treatments. Her research is crucial in advancing the understanding and management of auto-immune diseases.
Collaborations
Kuroiwa collaborates with esteemed colleagues, including Minako Araake and Hiroshi Suwa. Their combined expertise enhances the research and development of effective treatment methods.
Conclusion
Yukari Kuroiwa's contributions to the field of photochemotherapy represent a significant advancement in the treatment of auto-immune diseases. Her innovative methods and collaborative efforts are essential in shaping the future of medical therapies.